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Cerebral  blood  ﬂow (CBF)  and  oxygenation  (COx)  are  generally  well-preserved  in  COPD.  It is unknown
whether  prevalent  cardiovascular  co-morbidities,  such  as heart  failure,  may  impair  CBF  and  COx
responses  to exertion.  Eighteen  males  with  moderate-to-severe  COPD  (8 with  and  10 without  overlap-
ping  heart  failure)  underwent  a progressive  exercise  test  with  pre-frontal  CBF  and COx  measurements
(indocyanine  green  and near-infrared  spectroscopy).  Mean  arterial  pressure  and  cardiac  output  were
lower  from  rest to  exercise  in  overlap.  Only  COPD patients  demonstrated  an  increase  in arterialized  PCO2erebral oxygenation
hronic obstructive pulmonary disease
omorbidity
ear-infrared spectroscopy
towards  the  end  of  progressive  exercise.  CBF  index  was consistently  higher  and  increased  further  by
∼40%  during  exercise  in  COPD  whereas  a ∼10% reduction  was  observed  in  overlap.  COx  was  lower  in
overlap  despite  preserved  arterial  oxygenation.  In  conclusion,  heart  failure  introduces  pronounced  nega-
tive effects  on  CBF  and  COx  in  COPD  which  may  be associated  with  clinically  relevant  outcomes,  including
dyspnea,  exercise  intolerance,  cerebrovascular  disease  and  cognitive  impairment.. Introduction
Cerebral blood ﬂow (CBF) is regulated via the integration of mul-
iple physiological adjustments, including those in blood pressure,
ardiac output, neurovascular coupling, arterial blood gas tensions
nd autonomic nervous system activation (Ogoh and Ainslie, 2009;
illie et al., 2014; Brassard et al., 2014). Physical exercise inﬂuences
ll of these processes making CBF regulation a formidable chal-
enge for patients with cardiopulmonary and metabolic diseases
Kim et al., 2012, 2015).
In this context, it is rather surprising that patients with sta-
le chronic obstructive pulmonary disease (COPD) usually present
ith preserved (or increased) CBF at rest (Yildiz et al., 2012;
ornwell and Levine, 2015; Alosco and Hayes, 2015) and during
xercise (Oliveira et al., 2012; Vogiatzis et al., 2013; Hartmann
t al., 2014). This ﬁnding might be explained by their tendency to
pregulate PaCO2, a potent cerebral vasodilator (Ogoh and Ainslie,
009). This might become more evident during exercise as patients
re frequently unable to increase ventilation to properly wash-out
∗ Corresponding author at: 102 Stuart Street, Kingston, Ontario, K7L 2V6, Canada.
ax: +1 613 549 1459.
E-mail address: alberto.neder@queensu.ca (J.A. Neder).
ttp://dx.doi.org/10.1016/j.resp.2015.10.005
569-9048/© 2015 Elsevier B.V. All rights reserved.© 2015  Elsevier  B.V.  All  rights  reserved.
CO2 released from lactate buffering or, in more severe COPD, CO2
derived from cellular metabolism (O’Donnell et al., 2014). At least
in those who  are not overtly hypoxemic at rest, effective cere-
bral vasodilation may  offset mild-to-moderate decrements in PaO2
thereby preserving cerebral oxygenation (COx) (Jensen et al., 2002;
Van de Ven et al., 2001). In fact, we (Oliveira et al., 2012) and oth-
ers (Higashimoto et al., 2011) have found similar increases in COx
(measured by near-infrared spectroscopy) during exercise in non-
to mildly-hypoxemic COPD patients and healthy controls.
A different scenario, however, may  emerge in the presence of a
common and disabling co-morbidity of COPD: heart failure (Rutten
et al., 2006; Güder and Rutten, 2014). In fact, impaired resting CBF,
(Choi et al., 2006; Kim et al., 2012) which is further worsened under
the stress of exercise, (Koike et al., 2004, 2006; Fu et al., 2011) has
been reported in heart failure with reduced left ventricular ejection
fraction. These abnormalities have been ascribed to the combined
effects of impaired cerebral auto-regulation, decreased mean arte-
rial pressure and cardiac output, alveolar hyperventilation (i.e., low
PaCO2) and sympathetic over-excitation. (Alosco and Hayes, 2015)
Of note, patients with coexistent COPD-heart failure (“overlap”)
have higher prevalence of cerebrovascular disease (Rutten et al.,
2006; Güder and Rutten, 2014) and cognition disorders (Alosco
et al., 2014) than COPD patients without heart failure. Interest-
ingly, we  found previously lower COx during rapidly-incremental
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gig. 1. Cerebral blood ﬂow index (BFI) calculation based on indocyanine green kinet
xercise in overlap compared to COPD (Oliveira et al., 2013). Col-
ectively, these ﬁndings prompted the hypothesis that the reported
protective” effects of COPD on exercise CBF could be overridden by
he ominous pathophysiological consequences of heart failure on
erebral hemodynamics (Koike et al., 2004; Choi et al., 2006; Koike
t al., 2006; Fu et al., 2011; Kim et al., 2012).
The aim of this study was thus to investigate the inﬂuence of
eart failure on CBF and COx in COPD patients from rest to exercise.
e speciﬁcally postulated that, compared with age- and gender-
atched COPD, overlap patients would present with reduced CBF
hereby leading to lower COx.
. Methods
.1. Subjects
Eighteen sedentary males with well-established moderate-to-
evere COPD (Global Initiative for Obstructive Lung Disease stages
 and 3) (Vestbo et al., 2013) comprised the study group. Eight
atients had echocardiographic evidences of heart failure with
educed left ventricular ejection fraction (<50%). Patients were seen
rospectively by the same respirologists and cardiologists. Dis-
ase treatment for both diseases was decided by consensus and
ptimized carefully before study entry. Main exclusion criteria
ncluded: long-term O2 therapy, recent (within a year) rehabilita-
ion, previous stroke or transitory ischemic attack, osteomuscular
imitation to cycling, type I or non-controlled type II diabetes mel-
itus and clinical history of peripheral (including carotidal) arterial
isease. All subjects gave written informed consent and the study
as approved by the Medical Ethics committee of the Sao Paulo
ospital, Sao Paulo, Brazil.
.2. Measurements.2.1. Lung function
Spirometry, lung diffusing capacity, and static lung volumes
ere evaluated (1085 ELITE DTM, Medical Graphics). Resting blood
ases were obtained from samples from the radial artery.asured by near-infrared spectroscopy in representative COPD and overlap patients.
2.2.2. Cardiopulmonary exercise testing
Patients performed a four-stage (4 min  each with 4 min  rest
in-between) cycle ergometer test at 20%, 40%, 60% and 80% of
the peak workload (WRpeak) achieved on a previous incremental
test. Oxygen uptake (
·
VO2, mL/min), carbon dioxide output (
·
VCO2,
mL/min), respiratory exchange ratio (R), minute ventilation (
·
VE,
L/min) and end-tidal partial pressure for CO2 (PETCO2, mmHg)
were obtained breath-by-breath and averaged into 20s bins. Car-
diac output (L/min) was  assessed continuously by a calibrated
signal-morphology impedance cardiography system (Physioﬂow
PF-5TM, Manatec) (Charloux et al., 2000). Arterial oxygen saturation
was measured non-invasively by pulse oximetry (SpO2, %). Breath-
lessness and leg effort were rated according to the 10-point Borg
category-ratio scale every minute. Blood gases were measured from
arterialized (art) earlobe capillary samples concomitantly to CBF,
i.e., at the 3rd min  of each stage as described below.
2.2.3. Cerebral blood ﬂow & oxygenation
Continuous-wave, spatially-resolved near-infrared spec-
troscopy (NIRS) was  used to measure COx (changes in
oxyhemoglobin concentration ([O2Hb], mol/L) and tissue
oxygenation index (TOI, %)) and, by injecting the light-absorbing
tracer indocyanine green (ICG) dye, (pre-frontal cortical) CBF
(Kuebler et al., 1998; Habazettl et al., 2010) (NIRO 200, Hama-
matsu Photonics KK, Hamamatsu, Japan). One set of NIRS optodes
was placed on the skin over the left pre-frontal cortex region of the
forehead, secured using double-sided adhesive tape and hold with
a custom-built net headset. The optode separation distance was
4 cm,  corresponding to a penetration depth of ∼2 cm.  The spec-
trophotometer measured ICG concentration following a 5 mg/mL
bolus injection of ICG in the right forearm vein. ICG injections were
performed during the third minute of exercise. Given that light
attenuation is inﬂuenced by ICG, O2Hb and deoxyhaemoglobin,
the independent contribution of ICG was assessed using a matrix
operation that incorporates pathlength-speciﬁc extinction coefﬁ-
cients for each of the light absorbing chromophores (Hamamatsu
Photonics KK). As proposed by Kuebler et al. (1998), a CBF index
was calculated as the maximal change in ICG divided by its rise
time (10–90% amplitude) (mol/s) (Fig. 1).
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Table  1
Resting and peak exercise variables in COPD and overlap patients.
COPD (n = 10) Overlap (n = 8)
General characteristics
Age (yrs) 65 ± 8 65 ± 6
Weight (kg) 60 ± 8 72 ± 5*
Height (cm) 164 ± 78 166 ± 28
Body mass index (kg/m2) 22 ± 3 25 ± 2*
Packs/year 38 ± 7 33 ± 5
Left  ventricular ejection fraction (%) 64 ± 13 30 ± 5*
Main co-morbidities
Hypertension 6 5
Type II diabetes 5 6
Hypercolesterolemia 1 3
Lung function
FVC (% pred) 84 ± 12 72 ± 9
FEV1 (% pred) 44 ± 15 54 ± 8
FEV1/FVC 41 ± 11 55 ± 7*
TLC (% pred) 111 ± 13 87 ± 21*
RV (% pred) 165 ± 30 128 ± 35*
DLCO (% pred) 68 ± 21 63 ± 4
PaO2 (mmHg) 57 ± 9 64 ± 3
PaCO2 (mmHg) 39 ± 6 34 ± 1
Peak exercise
Work rate (W)  57 ± 18 52 ± 16
Work rate (% pred) 57 ± 16 46 ± 15
·
VO2 (mL/min) 1018 ± 180 1080 ± 275
·
VO2 (% pred) 69 ± 11 60 ± 13
·
VCO2 (mL/min) 1060 ± 259 1082 ± 351
RER 1.06 ± 0.25 1.08 ± 0.35
·
VE (L/min) 37.7 ± 11.3 40.6 ± 14.0
Heart rate (% pred) 85 ± 13 68 ± 18*
SpO2 (%) 87 ± 5 93 ± 3*
Dyspnea score 7 ± 2 9 ± 1
Leg effort score 7 ± 2 10 ± 1*
Values are mean ± SD or frequencies. Abbreviations: FVC = forced vital capacity;
FEV1 = forced expiratory volume in 1 s; TLC = total lung capacity; RV = resid-
ual volume; DLCO = lung diffusing capacity for carbon monoxide; PaO2 = arterial
partial pressure for oxygen; PaCO2 = arterial partial pressure for carbon diox-
ide;
·
VO2 = oxygen uptake;
·
VCO2 = carbon dioxide production; RER = respiratory
e
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* p < 0.05.
.3. Statistical analysis
Results are reported as means ± SD, unless stated otherwise.
OPD and overlap patients were contrasted by non-paired t or
ann–Whitney’s test or a 2 test for differences in proportions.
wo-way analysis of variance was used to assess between-group
ifferences at a given time point and intra-group differences (exer-
ise vs. rest). Statistical signiﬁcance was set at p < 0.05.
. Results
.1. Patients’ characteristics at rest and peak exercise
All patients were under triple therapy for COPD (long-acting
nti-muscarinics and 2-adrenoceptor agonists/inhaled corticos-
eroids). In addition, overlap patients were receiving selective
-blockers, ACE inhibitors and diuretics. As shown in Table 1,
OPD and overlap groups were well-matched by age and main
o-morbidities. Overlap patients, however, were heavier than their
ounterparts with COPD. As expected, while COPD patients showed
n obstructive pattern with hyperinﬂation and air trapping, over-
ap patients had mixed obstructive and restrictive abnormalities.
ung diffusing capacity (DLCO) did not differ between groups. There
ere also no between-group differences in WRpeak and peak
·
VO2. & Neurobiology 221 (2016) 41–48 43
However, peak SpO2 was  lower in overlap compared to COPD
(p < 0.05). As expected from -blocker usage, overlap had greater
heart rate reserves at exercise termination. Of note, they showed
greater symptom burden, particularly regarding to leg effort scores
(Table 1).
3.2. Metabolic, ventilatory and sensory responses
As anticipated from similar WRpeak, COPD and overlap exercised
at similar work rate and metabolic demands (and thus O2 and
·
VCO2)
at each submaximal exercise intensity (Table 2). Absolute and rel-
ative (to
·
VCO2) ventilatory responses, however, were greater in
overlap patients. For instance, while
·
VE increased ∼13 L/min from
20% to 80% WRpeak in COPD, it increased ∼20 L/min in overlap. Con-
sequently,
·
VE/
·
VCO2 was signiﬁcantly higher (and PETCO2 lower)
at 60% and 80% WRpeak in overlap (p < 0.05). Similar to maximal
exercise, leg effort scores were higher at 80% WRpeak in overlap
compared to COPD (Table 2).
3.3. Pulmonary gas exchange responses
There were marked between-group differences in arterial blood
gases during exercise. For instance, while SpO2 (%) progressively
decreased in COPD (∼10 unities less from rest to 80% WRpeak), it
remained remarkably stable in overlap (Fig. 2A). As shown in Fig. 2B,
Part CO2 increased by 2–3 mmHg  from rest to 20% WRpeak in both
groups. Thereafter, Part CO2 remained stable at around 40 mmHg
in COPD and decreased by ∼3 mmHg  from 20% to 80% WRpeak in
overlap. As a consequence, Part CO2 at 80% WRpeak was  signiﬁcantly
lower in overlap compared to COPD (p < 0.05).
3.4. Cardiovascular and hemodynamic responses
Stroke volume and, particularly, heart rate were lower from rest
to exercise (i.e., rest, 20 and 80% WRpeak) in overlap (Fig. 3, upper
panels). Thus, cardiac output was downwardly shifted during exer-
cise in that group (i.e., rest, 20 and 80% WRpeak; Fig. 3C). In fact,
while cardiac output increased more than 5 L/min from rest to 80%
WRpeak in COPD, it increased only ∼2 L/min in overlap (Fig. 3C).
Mean arterial pressure was also consistently lower across exercise
intensities in overlap (∼20 mmHg  less; Fig. 3D).
3.5. Cerebral blood ﬂow and oxygenation
Resting CBF in overlap was  markedly lower compared to COPD
(p < 0.01). In addition, whereas CBF increased 41.1 ± 8.9 % from
rest to 80% WRpeak in COPD it decreased 10.2 ± 8.2 % in over-
lap. CBF thus remained consistently lower throughout exercise
in overlap (Fig. 2C). As shown in Fig. 4, this was related both to
lower ICG amplitude and slower rising time (p < 0.01). COx analy-
ses showed that the area under the curve of exercising O2Hb and
TOI responses were also signiﬁcantly lower in overlap compared
to COPD (427 ± 110 a.u. vs. 1101 ± 323 a.u. and 5395 ± 230 a.u. vs.
7406 ± 476 a.u., respectively; p < 0.01). Furthermore, while discrete
HbO2 values increased on average ∼10 mol  from rest to 80%
WRpeak in COPD (p < 0.05), they failed to increase during exercise in
overlap (Fig. 2D).
4. DiscussionThis is the ﬁrst study to demonstrate that marked impairments
in resting cerebral (pre-frontal) blood ﬂow (CBF) are further ampli-
ﬁed under the stress of exercise in COPD patients presenting heart
failure as co-morbidity (“overlap”). Cerebral oxygenation (COx) was
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Table  2
Physiological and sensory responses at standardized sub-maximal exercise intensities in COPD and overlap patients.
20% Peak 40% Peak 60% Peak 80% Peak
COPD Overlap COPD Overlap COPD Overlap COPD Overlap
Work rate (W)  11 ± 3 9 ± 5 25 ± 7 23 ± 2 35 ± 11 35 ± 2 47 ± 15 43 ± 12
·
VO2 (mL/min) 611 ± 106 613 ± 181 711 ± 107 709 ± 204 820 ± 122 978 ± 230 1032 ± 270 982 ± 109
·
VCO2 (mL/min) 564 ± 110 552 ± 200 673 ± 132 739 ± 250 808 ± 181 942 ± 330 1045 ± 336 1082 ± 219
RER  0.92 ± 0.05 0.88 ± 0.06 0.94 ± 0.07 0.90 ± 0.09 0.97 ± 0.08 0.83 ± 0.12 1.00 ± 0.78 1.08 ± 0.09
·
VE (L/min) 21.9 ± 4.8 22.7 ± 6.5 25.2 ± 5.5 29.4 ± 7.5 28.4 ± 7.0 36.5 ± 8.8* 34.9 ± 14.5 42.1 ± 10.1*
·
VE/
·
VCO2 39 ± 5 42 ± 5 38 ± 4 41 ± 4 35 ± 5 39 ± 2* 33 ± 6 40 ± 5*
PETCO2 (mmHg) 38 ± 5 33 ± 5 38 ± 5 32 ± 4 40 ± 6 36 ± 3* 42 ± 7 32 ± 6*
Dyspnea score 2 ± 1 0.5 ± 1 3 ± 2 3 ± 1 7 ± 4 5 ± 3 8 ± 3 5 ± 2*
Leg effort score 1 ± 0.5 2 ± 1 2 ± 1 4 ± 2 4 ± 2 6 ± 2 5 ± 3 9 ± 4*
COPD vs. overlap.
·
VO2 = oxygen consumption;
·
VCO2 = carbon dioxide production; RER = respiratory exchange ratio;
·
VE; minute ventilation; PETCO2 = end tidal partial for
carbon  dioxide.
* p < 0.05.
F and c
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iig. 2. Arterial oxygen saturation, arterialized partial pressure of carbon dioxide 
ymbols).
Between-group differences at a given time point; †  intra-group differences versus 
lso signiﬁcantly reduced in overlap despite better preserved arte-
ial oxygenation compared to COPD without heart failure. These
bnormalities were associated with lower systemic perfusion pres-
ure (↓mean arterial pressure) and ﬂow (↓cardiac output) together
ith lower tensions of a potent cerebral vasodilator (↓PaCO2).
his study sets the scene for future investigations aimed at relat-
ng CBF and COx with clinically-relevant outcomes in overlap,erebral blood ﬂow and oxygenation in COPD (open symbols) and overlap (closed
including dyspnea, (Higashimoto et al., 2011) exercise intolerance,
(Mentz et al., 2013; Oliveira et al., 2014) cerebrovascular disease
(Nagayama et al., 2007) and cognitive impairment (Leto and Feola,
2014).There is growing recognition that heart failure has devastating
consequences for patients with COPD (Rutten et al., 2006; Güder
and Rutten, 2014). Unfortunately, little is known on how these
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Between-group differences at a given time point; †  intra-group differences versus 
omplex diseases interact to increase morbidity and mortality. The
resent study sheds light on a hitherto unexplored pathophysio-
ogical consequence of COPD-heart failure coexistence: impaired
BF and COx. The present data show that, while already present
t rest, these abnormalities were magniﬁed upon exertion (Fig. 2).
his indicates that required adjustments to maintain, or increase,
BF and COx were particularly dysfunctional under challenging
hysiological conditions in overlap compared to COPD.
In this context, it should be recognized that CBF regulation
uring exercise is inﬂuenced by several physiological factors in
ddition to cerebral metabolic and neuronal activity (Ogoh and
inslie, 2009). For instance, previous studies showed that a 1 mmHg
ncrease and decrease in PaCO2 led to an approximate 3–6% increase
nd 1–3% decrease in CBF, respectively (as reviewed by Willie
t al., 2014). Even considering that potential impairments in cere-
rovascular reactivity to CO2 may  have lessened these variations
n CBF, (Xie et al., 2005) Part CO2 (and PETCO2) in the present
tudy were typically lower during exercise in overlap compared to
OPD. It is also noteworthy that between-group differences in Part
O2 and CBF concomitantly widened from 60% to 80% peak exer-
ise (Fig. 2B and C). Lower Part CO2 can be explained by greater· ·
entilatory responses to metabolic demand (i.e., higher VE/VCO2)
ound in overlap (Table 2), a well-known physiological correlate
f heart failure (Piepoli et al., 2010). Although hyperventilationse test in COPD (open symbols) and overlap (closed symbols).
likely attenuated exertional hypoxemia (Fig. 2A), this was out-
weighed by lower CBF as COx was signiﬁcantly impaired in overlap
(Fig. 2D), i.e., O2 delivery was  possibly insufﬁcient to meet cere-
bral O2 demands. In contrast, COPD patients maintained stable
Part CO2 values throughout exercise, likely secondary to worsening
mechanical-ventilatory constraints (O’Donnell et al., 2014) induced
by higher operating lung volumes (Table 1). In this sense, the “pro-
tective” effects of exertional hypercapnia on CBF in COPD (Yildiz
et al., 2012; Oliveira et al., 2012; Vogiatzis et al., 2013; Hartmann
et al., 2014; Cornwell and Levine, 2015; Alosco and Hayes, 2015)
may  have been offset by alveolar hyperventilation due to higher
ventilatory drive in heart failure (Piepoli et al., 2010) combined
with COPD.
Another major putative mechanism for impaired CBF in overlap
patients was the consistently low mean arterial pressure (Fig. 3D).
Although cerebral auto-regulation has long been thought to main-
tain CBF over a large range of mean arterial pressures, (Lassen,
1959) this has been more recently disputed (Ogoh and Ainslie,
2009). In fact, this seems to be particularly relevant during exer-
cise where relatively mild decrements in mean arterial pressure
may  impair CBF (Willie et al., 2014). Moreover, there is recent
evidence that impairments in cardiac output can negatively inﬂu-
ence CBF during exercise, independently of PaCO2 and cerebral
auto-regulation (Ogoh et al., 2005). It could also be argued that
negative cardiopulmonary interactions in overlap (in addition to
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he negative chronotropic effects of -blockers) might lead to
reater decrements in cardiac output thereby further impairing
BF (Oliveira et al., 2014). In fact, even in COPD patients without
eart failure, improvements in cardiac output with non-invasive
entilation (under the same arterial oxygen content) (Rodrigues
t al., 2013) had positive effects on COx. Thus, lower cerebral per-
usion pressure (↓mean arterial pressure) and/or ﬂow (↓cardiac
utput) may  have compounded with higher intra-cerebral vessel
esistance (↓PaCO2) to impair CBF and COx in overlap. Collectively,
hese results illustrate the notion that CBF regulation in disease is a
omplex integrative process that involves pulmonary gas exchange
nd cardiovascular/hemodynamic function in addition to intracra-
ial mediators of cerebral vessel resistance (Willie et al., 2014).
There are other physiological derangements associated with
eart failure that might bear a negative inﬂuence on CBF in
verlap. Neurohumoral and/or metabolic factors such as the renin-
ngiotensin system, endothelin, adiponectin and other metabolitesrared spectroscopy in COPD (open symbols) and overlap (closed symbols).
have been related to chronic changes in vascular function (Choi
et al., 2006). Although controversial, (van Lieshout and Secher,
2008) it is also conceivable that elevated sympathetic nerve activity
may  induce cerebral vasoconstriction. In addition, abnormal arte-
rial baroreﬂex control of sympathetic nerve activity may  negatively
inﬂuence CBF during exercise (Ogoh et al., 2006).
The observed abnormalities on CBF and COx likely have rele-
vant implications for the clinical care of overlap patients. Firstly,
low CBF and COx might negatively inﬂuence patients’ cogni-
tion, (Alosco et al., 2014; Leto and Feola, 2014) an important
outcome related to disability and quality of life in COPD and
heart failure. Secondly, these derangements might lead to reduc-
tions in central motor drive to the working muscles (“central
fatigue”)(Oliveira et al., 2014) and/or increased perception of nega-
tive respiratory (Higashimoto et al., 2011) and muscular sensations
(Table 1) thereby contributing to early exercise termination. How-
ever, COPD and overlap had similar WRpeak (Table 1), suggesting
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hat those impairments did not contribute decisively to reduce
eak exercise capacity in the present study. Whether this also
olds true for endurance exercise tolerance remains to be inves-
igated. Thirdly, they provide plausible mechanistic bases for the
eported greater risk of overlap patients to develop cerebrovas-
ular disease and ischemic stroke (Mentz et al., 2013, 2014).
inally, CBF regulation might also be impaired in other con-
itions such as COPD exacerbation, (Yildiz et al., 2012) heart
ailure decompensation (Choi et al., 2006) and mechanical ven-
ilation (Cannizzaro et al., 1997). In those challenging situations,
ur results suggest that extra care should be taken to avoid
atrogenic reductions in cerebral perfusion induced by volume
epletion (excessive diuresis), low cardiac output (high intra-
horacic pressures) (Oliveira et al., 2014) or sudden decrease in the
revailing PaCO2 tensions (alveolar hyperventilation) (Cannizzaro
t al., 1997).
The present investigation has, naturally, some limitations. CBF
ndex by NIRS is only a relative measure of blood ﬂow, i.e., it is
roportional to ﬂow with an unknown factor of proportionality.
hus, BFI is better suited to intra- rather than inter-subject com-
arisons. (Habazettl et al., 2010) Nevertheless, Fig. 4 shows that
oth ICG kinetic parameters were consistently different, i.e. lower
mplitude and faster rate of increase in overlap compared to con-
rols. Thus, although our results showed a marked decrease in CBF
n overlap patients (Fig. 2C), we were unable to precise the extent
f those impairments. We  used O2Hb and TOI (which depends on
oth O2Hb and deoxy-Hb) to assess changes in COx during incre-
ental exercise. Owing to the fact that fractional O2 extraction
s substantially lower in the cerebral tissue compared to skele-
al muscle (Ogoh and Ainslie, 2009) and the inﬂuence of venous
lood volume on cerebral deoxy-Hb (Hoshi et al., 2001), the for-
er  likely reﬂects better changes in CBF under dynamic conditions.
hus, if HbO2 and HHb increase proportionally with CBF, cere-
ral TOI might become relatively stable. In fact, Hoshi et al. (2001)
ound that HbO2 was the most sensitive NIRS-based indicator of
hanges in CBF in a perfused rat brain model. Our patients had
o previous history/diagnosis of carotidal disease but we  cannot
ule out the hypothesis that worse extra-cranial atherosclerotic
isease contributed to lower CBF in overlap herein (Nagayama
t al., 2007). We  acknowledge that our sample is relatively small
nd certainly not representative of the whole spectrum of COPD
nd heart failure severity. Nevertheless, it is unlikely that sys-
ematic type II error was present as most of the between-group
ifferences were sufﬁciently large to reach statistical signiﬁcance
t the 5% level. The impact of heart failure on patients with end-
tage COPD showing overt respiratory insufﬁciency at rest (i.e.,
ypoxemia and/or hypercapnia) (Jensen et al., 2002) remains to
e investigated.
In conclusion, this is the ﬁrst demonstration that marked impair-
ents in resting CBF are worsened by the stress of exercise in
OPD patients presenting heart failure as co-morbidity. These
bnormalities precluded COx to increase throughout exercise, a
ikely consequence of the combined deleterious effects of systemic
emodynamic impairment and lower PaCO2 in overlap. If CBF and
Ox prove to be associated with clinically-relevant outcomes (e.g.,
yspnea, exercise intolerance, cerebrovascular disease and cogni-
ive impairment), cerebral hemodynamics and oxygenation may
ecome useful therapeutic targets for overlap patients.onﬂict of interest
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